吉西他滨联合卡铂新辅助化疗后立即行根治性膀胱切除术治疗肌层浸润性膀胱癌。 - Suppr

Suppr

超能文献

Neoadjuvant chemotherapy with gemcitabine plus carboplatin followed by immediate radical cystectomy for muscle-invasive bladder cancer.

作者信息

Ohyama Chikara, Hatakeyama Shingo, Yoneyama Takahiro, Koie Takuya

机构信息

Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

出版信息

Int J Urol. 2014 Jan;21(1):3-4. doi: 10.1111/iju.12230. Epub 2013 Aug 22.

DOI:10.1111/iju.12230

PMID:24033445

Abstract

摘要

相似文献

Neoadjuvant chemotherapy with gemcitabine plus carboplatin followed by immediate radical cystectomy for muscle-invasive bladder cancer.吉西他滨联合卡铂新辅助化疗后立即行根治性膀胱切除术治疗肌层浸润性膀胱癌。

Int J Urol. 2014 Jan;21(1):3-4. doi: 10.1111/iju.12230. Epub 2013 Aug 22.

The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy.对于不符合基于顺铂化疗条件的肌层浸润性膀胱癌患者，新辅助吉西他滨联合卡铂治疗后立即进行根治性膀胱切除术的效用。

Int J Clin Oncol. 2017 Feb;22(1):159-165. doi: 10.1007/s10147-016-1029-2. Epub 2016 Aug 17.

Efficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: a prospective single-arm study.新辅助吉西他滨联合卡铂治疗肌层浸润性膀胱癌（包括不能耐受顺铂者）后即刻行膀胱切除术的疗效和安全性：一项前瞻性单臂研究。

Int J Clin Oncol. 2013 Aug;18(4):724-30. doi: 10.1007/s10147-012-0447-z. Epub 2012 Jul 19.

Neoadjuvant gemcitabine plus carboplatin for locally advanced bladder cancer.新辅助吉西他滨加卡铂治疗局部晚期膀胱癌。

Jpn J Clin Oncol. 2013 Feb;43(2):193-9. doi: 10.1093/jjco/hys213. Epub 2012 Dec 28.

A phase II trial of neoadjuvant nab-paclitaxel, carboplatin, and gemcitabine (ACaG) in patients with locally advanced carcinoma of the bladder.一项新辅助纳武利尤单抗联合伊匹木单抗治疗晚期膀胱癌的 II 期临床试验。

Urology. 2013 Jul;82(1):111-7. doi: 10.1016/j.urology.2013.03.044. Epub 2013 May 21.

Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer.新辅助与辅助吉西他滨联合顺铂化疗治疗肌层浸润性膀胱癌的比较

Asia Pac J Clin Oncol. 2013 Dec;9(4):310-7. doi: 10.1111/ajco.12017. Epub 2012 Nov 6.

Expression of nucleoside transporters and deoxycytidine kinase proteins in muscle invasive urothelial carcinoma of the bladder: correlation with pathological response to neoadjuvant platinum/gemcitabine combination chemotherapy.核苷转运体和脱氧胞苷激酶蛋白在肌层浸润性膀胱癌中的表达：与新辅助铂类/吉西他滨联合化疗的病理反应相关性。

J Urol. 2014 Jan;191(1):35-9. doi: 10.1016/j.juro.2013.07.006. Epub 2013 Jul 10.

Neoadjuvant Chemotherapy for Patients with Muscle-invasive Urothelial Bladder Cancer Candidates for Curative Surgery: A Prospective Clinical Trial Based on Cisplatin Feasibility.适用于根治性手术的肌层浸润性尿路上皮膀胱癌患者的新辅助化疗：基于顺铂可行性的前瞻性临床试验

Anticancer Res. 2017 Nov;37(11):6453-6458. doi: 10.21873/anticanres.12100.

A sequential treatment approach to myoinvasive urothelial cancer: a phase II Southwest Oncology Group trial (S0219).肌层浸润性尿路上皮癌的序贯治疗方法：一项西南肿瘤协作组II期试验（S0219）

J Urol. 2009 Jun;181(6):2476-80; discussion 2480-1. doi: 10.1016/j.juro.2009.01.115. Epub 2009 Apr 16.

Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer.多中心前瞻性 II 期试验：新辅助剂量密集型吉西他滨联合顺铂治疗肌层浸润性膀胱癌。

J Clin Oncol. 2018 Jul 1;36(19):1949-1956. doi: 10.1200/JCO.2017.75.0158. Epub 2018 May 9.

引用本文的文献

Improving Urothelial Carcinoma Outcomes: The Powerful Combination of Neoadjuvant and Adjuvant Chemotherapy in the Perioperative Period.改善尿路上皮癌的治疗效果：围手术期新辅助化疗与辅助化疗的强效联合

Ann Surg Oncol. 2025 Mar 27. doi: 10.1245/s10434-025-17154-7.

The role of histological subtype and chemotherapy on prognosis of ureteral cancer.输尿管癌的组织学亚型和化疗对预后的作用。

J Cancer Res Clin Oncol. 2024 Apr 13;150(4):192. doi: 10.1007/s00432-024-05684-8.

Asymptomatic recurrence detection and cost-effectiveness in urothelial carcinoma.无症状复发病灶检测与尿路上皮癌的成本效益

Med Oncol. 2018 May 9;35(6):94. doi: 10.1007/s12032-018-1152-1.

Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study.局部晚期上尿路尿路上皮癌患者新辅助化疗的肿瘤学结局：一项多中心研究

Oncotarget. 2017 Oct 6;8(60):101500-101508. doi: 10.18632/oncotarget.21551. eCollection 2017 Nov 24.

Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study.日本肌层浸润性膀胱癌新辅助化疗的使用趋势及肿瘤学结局：一项多中心研究

Oncotarget. 2017 Sep 18;8(49):86130-86142. doi: 10.18632/oncotarget.20991. eCollection 2017 Oct 17.

Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer.肌层浸润性膀胱癌患者根治性膀胱切除术后风险分层监测及随访的成本效益

Oncotarget. 2017 Jul 6;8(39):65492-65505. doi: 10.18632/oncotarget.19043. eCollection 2017 Sep 12.

Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer.术前慢性肾病预示着肌层浸润性膀胱癌患者行根治性膀胱切除术后肿瘤学预后较差。

Oncotarget. 2017 May 29;8(37):61404-61414. doi: 10.18632/oncotarget.18248. eCollection 2017 Sep 22.

Quality-of-life evaluation during platinum-based neoadjuvant chemotherapies for urothelial carcinoma.铂类新辅助化疗治疗尿路上皮癌期间的生活质量评估。

Int J Clin Oncol. 2017 Apr;22(2):366-372. doi: 10.1007/s10147-016-1071-0. Epub 2016 Dec 8.

Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review.肌肉浸润性膀胱癌围手术期全身治疗的当前及近期临床试验：一项系统评价

BMC Cancer. 2014 Dec 16;14:966. doi: 10.1186/1471-2407-14-966.

A retrospective analysis of incidence and its associated risk factors of upper urinary tract recurrence following radical cystectomy for bladder cancer with transitional cell carcinoma: the significance of local pelvic recurrence and positive lymph node.膀胱癌伴移行细胞癌根治性膀胱切除术后上尿路复发的发生率及其相关危险因素的回顾性分析：盆腔局部复发和阳性淋巴结的意义

PLoS One. 2014 May 5;9(5):e96467. doi: 10.1371/journal.pone.0096467. eCollection 2014.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验